0.4090SEK+2.25%Mkt Cap: 166.30M SEKP/E: —Last update: 2026-06-05
iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automa…
Industry Peers
Medical Instruments & Supplies149.48BUSDP/E 51.2
86.47BDKKP/E 41.2
79.93BEURP/E 34.9
59.89BUSDP/E 29.5
41.65BUSDP/E 26.4
28.44BUSDP/E 18.9
25.91BCHFP/E 40.2
22.22BUSDP/E 42.0
Indicators:|
Key Statistics
Company
Market Cap166.30M SEK
Enterprise Value159.37M SEK
Revenue (TTM)7.09M SEK
Gross Profit2.40M SEK
Net Income (TTM)-16.68M SEK
Revenue/Share0.0200 SEK
Last Price0.4090 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.26
EV/Revenue22.47
P/S23.45
P/B6.82
EPS (TTM)-0.06
EPS (Forward)—
52W Range
0.230031% of range0.8000
52W High0.8000 SEK
52W Low0.2300 SEK
Profitability
Gross Margin40.13%
Oper. Margin-242.79%
EBITDA Margin-242.55%
Profit Margin-278.35%
ROE-142.71%
ROA-46.80%
Growth
Revenue Growth83.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.56M SEK
CapEx (TTM)660.00K SEK
FCF Margin10.43%
FCF Yield0.44%
Net Debt-6.93M SEK
Net Debt/EBITDA0.40
Balance Sheet
Debt/Equity0.00
Current Ratio0.99
Quick Ratio0.81
Book Value/Sh0.0600 SEK
Cash/Share0.0180 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split11:10
Split DateDec 7, 2011
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.405.99M
Float398.12M
Insiders0.00%
Institutions1.42%
Technical
SMA 500.3810 (+7.3%)
SMA 2000.4740 (-13.7%)
Beta-0.01
S&P 52W Chg27.18%
Avg Vol (30d)509.89K
Avg Vol (10d)370.96K
Technical Indicators
RSI (14)61.0
MACD0.0079
MACD Signal0.0029
MACD Hist.+0.0050
BB Upper0.4368 SEK
BB Middle0.3739 SEK
BB Lower0.3110 SEK
BB Width33.64%
ATR (14)0.0309 SEK
Vol Ratio (20d)0.26x